Amivantamab (FUT8-KO)
Product Specifications
Target
EGFR
Related Pathways
Angiogenesis|||Tyrosine Kinase/Adaptors|||JAK/STAT signaling
Bioactivity
Amivantamab (FUT8-KO) is a humanized dual-specificity antibody targeting EGFR-MET, with FUT8 knocked out, exhibiting immunotherapeutic anticancer activity. This compound inhibits ligand binding, enhances the internalization and degradation of receptor-antibody complexes, and stimulates macrophage-mediated phagocytosis and natural killer cell cytotoxicity, both of which are Fc-dependent.
Smiles
OC=1C=C2OC(=CC3(O)OC(=CC(C1)=C23)C)C
Molecular Formula
C13H12O4
Molecular Weight
232.23
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/264724928194936861/T9901A-232
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LS006584-20ug 20 µg
Solute carrier family 22 member 5 (SLC22A5) (NM_003060) Human Over-expression Lysate
Ask
View Details